Treatment of Breast Cancer with Aromatase Inhibitors--current Status and Future Prospects

Overview

Journal Br J Cancer

Specialty Oncology

Date 1989 Jul 1

PMID 2679845

Authors

P E Lonning

M Dowsett

T J Powles

Affiliations

Soon will be listed here.

References

DEXTER R, Fishman L, NEY R, LIDDLE G . Inhibition of adrenal corticosteroid synthesis by aminoglutethimide: studies of the mechanism of action. J Clin Endocrinol Metab. 1967; 27(4):473-80. DOI: 10.1210/jcem-27-4-473. View

Dao T, Tan E, BROOKS V . A comparative evaluation of adrenalectomy and cortisone in the treatment of advanced mammary carcinoma. Cancer. 1961; 14:1259-65. DOI: 10.1002/1097-0142(196111/12)14:6<1259::aid-cncr2820140616>3.0.co;2-4. View

Cash R, BROUGH A, Cohen M, SATOH P . Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial. J Clin Endocrinol Metab. 1967; 27(9):1239-48. DOI: 10.1210/jcem-27-9-1239. View

Cohen M . Aminoglutethimide inhibition of adrenal desmolase activity. Proc Soc Exp Biol Med. 1968; 127(4):1086-90. DOI: 10.3181/00379727-127-32877. View

FRACCHIA A, FARROW J, Miller T, Tollefsen R, Greenberg E, Knapper W . Hypophysectomy as compared with adrenalectomy in the treatment of advanced carcinoma of the breast. Surg Gynecol Obstet. 1971; 133(2):241-6. View

GRODIN J, Siiteri P, MACDONALD P . Source of estrogen production in postmenopausal women. J Clin Endocrinol Metab. 1973; 36(2):207-14. DOI: 10.1210/jcem-36-2-207. View

Thompson Jr E, Siiteri P . The involvement of human placental microsomal cytochrome P-450 in aromatization. J Biol Chem. 1974; 249(17):5373-8. View

Santen R, Lipton A, Kendall J . Successful medical adrenalectomy with amino-glutethimide. Role of altered drug metabolism. JAMA. 1974; 230(12):1661-5. View

Millington D, Jenner D, Jones T, Griffiths K . Endogenous steroid concentrations in human breast tumours determined by high-resolution mass fragmentography. Biochem J. 1974; 139(2):473-5. PMC: 1166305. DOI: 10.1042/bj1390473. View

10.

Vermeulen A . The hormonal activity of the postmenopausal ovary. J Clin Endocrinol Metab. 1976; 42(2):247-53. DOI: 10.1210/jcem-42-2-247. View

11.

NEWSOME H, Brown P, TERZ J, LAWRENCE Jr W . Medical and surgical adrenalectomy in patients with advanced breast carcinoma. Cancer. 1977; 39(2):542-6. DOI: 10.1002/1097-0142(197702)39:2<542::aid-cncr2820390224>3.0.co;2-r. View

12.

SAMOJLIK E, Santen R, Wells S . Adrenal suppression with aminoglutethimide. II. Differential effects of aminoglutethimide on plasma androstenedione and estrogen levels. J Clin Endocrinol Metab. 1977; 45(3):480-7. DOI: 10.1210/jcem-45-3-480. View

13.

Fishman J, Nisselbaum J, Schwartz M . Estrone and estradiol content in human breast tumors: relationship to estradiol receptors. J Steroid Biochem. 1977; 8(8):893-6. DOI: 10.1016/0022-4731(77)90100-5. View

14.

KIRSCHNER M, COHEN F, Ryan C . Androgen-estrogen production rates in postmenopausal women with breast cancer. Cancer Res. 1978; 38(11 Pt 2):4029-35. View

15.

Barone R, Shamonki I, Siiteri P, Judd H . Inhibition of peripheral aromatization of androstenedione to estrone in postmenopausal women with breast cancer using delta 1-testololactone. J Clin Endocrinol Metab. 1979; 49(5):672-6. DOI: 10.1210/jcem-49-5-672. View

16.

Santen R, Worgul T, SAMOJLIK E, Interrante A, Boucher A, Lipton A . A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer. N Engl J Med. 1981; 305(10):545-51. DOI: 10.1056/NEJM198109033051003. View

17.

Edery M, Goussard J, Dehennin L, Scholler R, Reiffsteck J, DROSDOWSKY M . Endogenous oestradiol-17beta concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content. Eur J Cancer (1965). 1981; 17(1):115-20. DOI: 10.1016/0014-2964(81)90220-6. View

18.

Smith I, Harris A, Morgan M, Ford H, Gazet J, Harmer C . Tamoxifen versus aminoglutethimide in advanced breast carcinoma: a randomized cross-over trial. Br Med J (Clin Res Ed). 1981; 283(6304):1432-4. PMC: 1507612. DOI: 10.1136/bmj.283.6304.1432. View

19.

Brodie A, Garrett W, Hendrickson J, Tsai-Morris C, Marcotte P, Robinson C . Inactivation of aromatase in vitro by 4-hydroxy-4-androstene-3,17-dione and 4-acetoxy-4-androstene-3,17-dione and sustained effects in vivo. Steroids. 1981; 38(6):693-702. DOI: 10.1016/0039-128x(81)90087-8. View

20.

Santen R, Santner S, Rosen H, SAMOJLIK E, Veldhuis J . In vivo and in vitro pharmacological studies of aminoglutethimide as an aromatase inhibitor. Cancer Res. 1982; 42(8 Suppl):3353s-3359s. View